← Back to headlines
AstraZeneca Shares Rise on Positive Lung Drug Trial Results
AstraZeneca's stock saw a boost after its new lung drug successfully met its objectives in late-stage clinical trials.
27 Mar, 15:34 — 27 Mar, 15:34
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippine Gaming Regulator Orders Promotion of National Problem Gambling Helpline
just now
Malaysia Aviation Group addresses aircraft availability amid disruptions
11m ago
Vodafone Australia experiences network outage affecting thousands
15m ago